Delivery Order SPE2DR25D6028-SPE2DR26FARVY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,108.54 to AmerisourceBergen Drug Corp for the supply of Humira Pen 40 mg/0.8 mL on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,441.44 to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. This firm fixed-price delivery order, with an ultimate completion date of November 13, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $7,659.60 to supply Humira Pen 40 mg/0.8 mL, with an ultimate completion date of November 10, 2025. This competitively awarded, non-set-aside delivery order represents a firm fixed price contract for pharmaceutical supplies to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.95 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mls on July 21, 2025, with a completion date of July 22, 2025. This firm fixed-price contract represents a non-set-aside competitive award for pharmaceutical supplies to support federal medical procurement needs. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,744.72 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a standard pharmaceutical supply transaction under the company's broader relationship with the federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,989.76 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used to treat inflammatory conditions. The award, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, carries a firm fixed price and represents a non-competitive delivery order. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $5,543.70 to AmerisourceBergen Drug Corp for the supply of Humira Pen 40 mg/0.8 mls, a pharmaceutical product used to treat inflammatory conditions. This competitively awarded, firm fixed-price contract was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $36,425.77 delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA Pen 40mg/4ml (2 units) under a firm fixed price contract. This delivery order, issued on October 27, 2025, with an ultimate completion date of November 24, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been selected to fulfill this medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.95 to AmerisourceBergen Drug Corp for the supply of Humira Pen 40 mg/0.8 mL units. This contract represents a firm fixed price delivery order with an ultimate completion date of July 15, 2025, and was awarded on July 14, 2025 with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Humira Pen 40 mg/0.8 mL with a ceiling value of $1,132.95. This is a firm fixed-price delivery order under a non-set-aside competitive award, with ultimate completion scheduled for July 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken,...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FARVYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $41,849.48 to AmerisourceBergen Drug Corp for the supply of Humira Pen 40mg/4ml (2-pack units) on November 18, 2025, with a completion date of November 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a small transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with a comprehensive range of medications and medical supplies. The Humira delivery supports the military healthcare system's immunological treatment requirements and exemplifies the company's role as a critical distributor of brand-name pharmaceuticals and specialized medical commodities to the Department of Defense and related federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.8k | 11/18/25 |